A unified multi-level model approach to assessing patient responsiveness including; return to normal, minimally important differences and minimal clinically important improvement for patient reported outcome measures
暂无分享,去创建一个
J. Dawson | A. Blom | A. Sayers | E. Lenguerrand | R. Gooberman-Hill | V. Wylde | D. Beard | A. Price
[1] P. Dieppe,et al. Trajectories of Pain and Function after Primary Hip and Knee Arthroplasty: The ADAPT Cohort Study , 2016, PloS one.
[2] P. Dieppe,et al. Rest Pain and Movement‐Evoked Pain as Unique Constructs in Hip and Knee Replacements , 2016, Arthritis care & research.
[3] P. Dieppe,et al. 45-day mortality after 467 779 knee replacements for osteoarthritis from the National Joint Registry for England and Wales: an observational study , 2014, The Lancet.
[4] A. Beswick,et al. Assessment of Chronic Postsurgical Pain After Knee Replacement: A Systematic Review , 2013, Arthritis care & research.
[5] P. Dieppe,et al. 90-day mortality after 409 096 total hip replacements for osteoarthritis, from the National Joint Registry for England and Wales: a retrospective analysis , 2013, The Lancet.
[6] P. Dieppe,et al. An analysis of time and money spent on investigating painful total knee replacements , 2012 .
[7] Rachael Gooberman-Hill,et al. What proportion of patients report long-term pain after total hip or knee replacement for osteoarthritis? A systematic review of prospective studies in unselected patients , 2012, BMJ Open.
[8] A. Blom,et al. The failure of survivorship. , 2011, The Journal of bone and joint surgery. British volume.
[9] M. King. A point of minimal important difference (MID): a critique of terminology and methods , 2011, Expert review of pharmacoeconomics & outcomes research.
[10] P. Dieppe,et al. The effect of local anaesthetic wound infiltration on chronic pain after lower limb joint replacement: A protocol for a double-blind randomised controlled trial , 2011, BMC musculoskeletal disorders.
[11] A. Blom,et al. “It's there and I'm stuck with it”: Patients' experiences of chronic pain following total knee replacement surgery , 2011, Arthritis care & research.
[12] C. Cooper,et al. Patient‐reported outcomes one year after primary hip replacement in a European Collaborative Cohort , 2010, Arthritis care & research.
[13] Daniel S Nagin,et al. Group-based trajectory modeling in clinical research. , 2010, Annual review of clinical psychology.
[14] Nilam Ram,et al. Methods and Measures: Growth mixture modeling: A method for identifying differences in longitudinal change among unobserved groups , 2009, International journal of behavioral development.
[15] J. Twisk,et al. Longitudinal tobit regression: a new approach to analyze outcome variables with floor or ceiling effects. , 2009, Journal of clinical epidemiology.
[16] P. Stratford,et al. Findings of extensive variation in the types of outcome measures used in hip and knee replacement clinical trials: a systematic review. , 2008, Arthritis and rheumatism.
[17] R. Hays,et al. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. , 2008, Journal of clinical epidemiology.
[18] S. Gabriel,et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. , 2008, Arthritis and rheumatism.
[19] T. Kvien,et al. Minimal clinically important improvement/difference (MCII/MCID) and patient acceptable symptom state (PASS): what do these concepts mean? , 2007, Annals of the rheumatic diseases.
[20] Sophia Rabe-Hesketh,et al. Multilevel and Latent Variable Modeling with Composite Links and Exploded Likelihoods , 2007 .
[21] A. Boonen,et al. Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis. , 2007, Arthritis and rheumatism.
[22] Geert Verbeke,et al. Pairwise Fitting of Mixed Models for the Joint Modeling of Multivariate Longitudinal Profiles , 2006, Biometrics.
[23] W. Ambrosius,et al. Exercise, self-efficacy, and mobility performance in overweight and obese older adults with knee osteoarthritis. , 2005, Arthritis and rheumatism.
[24] Geert Verbeke,et al. Joint modelling of multivariate longitudinal profiles: pitfalls of the random‐effects approach , 2004, Statistics in medicine.
[25] C. Bombardier,et al. Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement , 2004, Annals of the rheumatic diseases.
[26] C. Bombardier,et al. Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state , 2004, Annals of the rheumatic diseases.
[27] M. Dougados,et al. OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. , 2004, Osteoarthritis and cartilage.
[28] C. Zwingmann,et al. The ‘smallest real difference’ as a measure of sensitivity to change: a critical analysis , 2003, International journal of rehabilitation research. Internationale Zeitschrift fur Rehabilitationsforschung. Revue internationale de recherches de readaptation.
[29] G. Norman,et al. Interpretation of Changes in Health-related Quality of Life: The Remarkable Universality of Half a Standard Deviation , 2003, Medical care.
[30] M. Klässbo,et al. Hip disability and osteoarthritis outcome scoreAn extension of the Western Ontario and McMaster Universities Osteoarthritis Index , 2003, Scandinavian journal of rheumatology.
[31] Gordon H Guyatt,et al. Methods to explain the clinical significance of health status measures. , 2002, Mayo Clinic proceedings.
[32] A. Davis,et al. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties. , 2001, Arthritis and rheumatism.
[33] Jonathan A C Sterne,et al. Sifting the evidence—what's wrong with significance tests? , 2001, BMJ : British Medical Journal.
[34] William J. Browne,et al. Implementation and performance issues in the Bayesian and likelihood fitting of multilevel models , 2000, Comput. Stat..
[35] N. Jacobson,et al. Methods for defining and determining the clinical significance of treatment effects: description, application, and alternatives. , 1999, Journal of consulting and clinical psychology.
[36] H Goldstein,et al. Multi-level repeated measures growth modelling using extended spline functions. , 1998, Statistics in medicine.
[37] M. Kenward,et al. Small sample inference for fixed effects from restricted maximum likelihood. , 1997, Biometrics.
[38] N. Bellamy,et al. Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials--results of a consensus development (Delphi) exercise. , 1992, The Journal of rheumatology.
[39] N. Jacobson,et al. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. , 1991, Journal of consulting and clinical psychology.
[40] C. Goldsmith,et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. , 1988, The Journal of rheumatology.
[41] L. Kazis,et al. The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. , 1987, Arthritis and rheumatism.
[42] Huston Gj,et al. The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.
[43] Jorge L. Mendoza,et al. A method of assessing change in a single subject: An alteration of the RC index , 1986 .
[44] M. Gardner,et al. Statistical guidelines for contributors to medical journals. , 1983, British medical journal.
[45] A. Carr,et al. Questionnaire on the perceptions of patients about total knee replacement. , 1998, The Journal of bone and joint surgery. British volume.
[46] A. Carr,et al. Questionnaire on the perceptions of patients about total hip replacement. , 1996, The Journal of bone and joint surgery. British volume.